Your browser doesn't support javascript.
loading
Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted.
Ward, Katie; Spurr, Lydia; Goldman, Nina R; Margaritopoulos, George A; Kokosi, Maria; Renzoni, Elizabetta; Chua, Felix; Maher, Toby M; Ward, Simon; Wells, Athol U.
Afiliación
  • Ward K; Department of Respiratory Medicine, Royal Free Hospital, Pond Street, London, NW3 2QG, United Kingdom. Electronic address: katieward@nhs.net.
  • Spurr L; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom.
  • Goldman NR; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom.
  • Margaritopoulos GA; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom.
  • Kokosi M; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom.
  • Renzoni E; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom.
  • Chua F; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom.
  • Maher TM; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom; NIHR Biomedical Research Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom; Fibrosis Research Group, National Heart and Lung Instit
  • Ward S; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom.
  • Wells AU; Interstitial Lung Disease Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom.
Respir Med ; 120: 131-133, 2016 11.
Article en En | MEDLINE | ID: mdl-27817810
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Capacidad Vital / Fibrosis Pulmonar Idiopática Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Respir Med Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Capacidad Vital / Fibrosis Pulmonar Idiopática Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Respir Med Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido